Chemours Reports Better Than Expected Q1 Results
<p><a href='https://financialmodelingprep.com/financial-summary/CC'>Chemours (NYSE:CC)</a> reported its Q1 earnings on Thursday, with EPS coming in at $0.98, better than the Street estimate of $0.54. Revenue was $1.6 billion, beating the Street estimate of $1.46 billion.</p>
<p>The company reaffirmed its 2023 EBITDA guidance of $1.2–1.3 billion, compared to the Street estimate of $1.24 billion. Adjusted EPS guidance is essentially unchanged at $3.78–4.28, compared to the prior guidance of $3.80-$4.29.</p>
<p>The company expects a weaker start to 2023, with conditions improving into the second half of the year, with continued secular growth in TSS and APM.</p>

NYSE:CC